Katrina Goddard is Distinguished Investigator and Associate Director of the Science Programs at Kaiser Permanente Center for Health Research in Portland, OR. Katrina is genetic epidemiologist who focuses on public health genomics and the translation of genetic testing into practice. Prior to joining the Kaiser Permanente Center for Health Research in 2007, she was faculty in the Department of Epidemiology and Biostatistics (now Population and Quantitative Health Sciences) at Case Western Reserve University in Cleveland, OH. She was also a mid-career fellow at the Centers for Disease Control and Prevention in Genetics & Public Health Research and Practice. At Kaiser, she was the founding director for the NW Biobank, and she is currently a PI of Kaiser's Cancer Health Assessments Reaching Many (CHARM) study as part of the National Human Genome Research Institute (NHGRI)-funded Clinical Sequencing Evidence-Generating Research (CSER2) consortium.
Recent Publications
- Chambers, DA, Goddard, KAB. Advancing Implementation Science in Cancer Genomics: Progressing from Discovery to Population Health Benefit. Public Health Genomics 2024; 27 (1): 161-167. PubMed PMID:39374589 .
- Goddard, KAB, Feuer, EJ, Umar, A, Castle, PE. Accelerating Progress to Reduce the Cancer Burden through Prevention and Control in the US. J Natl Cancer Inst 2024; : . PubMed PMID:39222932 .
- Pak, CM, Gilmore, MJ, Bulkley, JE, Chakraborty, P, Dagan-Rosenfeld, O, Foreman, AKM, Gollob, MH, Jenkins, CL, Katz, AE, Lee, K et al.. Implementing evidence-based assertions of clinical actionability in the context of secondary findings: Updates from the ClinGen Actionability Working Group. Genet Med 2024; 26 (8): 101164. PubMed PMID:38757444 PubMed Central PMC11298308.
- Lewis, H, Biesecker, B, Lee, SS, Anderson, K, Joseph, G, Jenkins, CL, Bulkley, JE, Leo, MC, Goddard, KAB, Wilfond, BS et al.. Promoting equity, inclusion, and efficiency: A team science approach to the development of authorship guidelines for a multi-disciplinary research team. J Clin Transl Sci 2023; 7 (1): e265. PubMed PMID:38229898 PubMed Central PMC10790100.
- Gilmore, MJ, Leo, MC, Amendola, LM, Goddard, KAB, Ezzell Hunter, J, Joseph, G, Kauffman, TL, Rolf, B, Shuster, E, Zepp, JM et al.. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population. Transl Behav Med 2024; 14 (7): 377-385. PubMed PMID:38190737 PubMed Central PMC11208290.
- Klein, WMP, Dwyer, LA, Goddard, KAB. The Long Behavioral Tail of the COVID-19 Pandemic-A Cancer Control Perspective. JAMA Oncol 2024; 10 (2): 159-160. PubMed PMID:38060244 PubMed Central PMC11308860.
- Guo, B, Knerr, S, Kauffman, TL, Mittendorf, KF, Keast, E, Gilmore, MJ, Feigelson, HS, Lynch, FL, Muessig, KR, Okuyama, S et al.. Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. Cancer Med 2023; 12 (18): 19112-19125. PubMed PMID:37644850 PubMed Central PMC10557878.
- Knerr, S, Guo, B, Wernli, KJ, Mittendorf, KF, Feigelson, HS, Gilmore, MJ, Jarvik, GP, Kauffman, TL, Keast, E, Liles, EG et al.. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Res Treat 2023; 201 (3): 461-470. PubMed PMID:37470892 PubMed Central PMC10503958.
- Hunter, JE, Riddle, L, Joseph, G, Amendola, LM, Gilmore, MJ, Zepp, JM, Shuster, E, Bulkley, JE, Muessig, KR, Anderson, KP et al.. Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population. Genet Med 2023; 25 (11): 100923. PubMed PMID:37421176 PubMed Central PMC10766857.
- Turbitt, E, Kohler, JN, Angelo, F, Miller, IM, Lewis, KL, Goddard, KAB, Wilfond, BS, Biesecker, BB, Leo, MC. The PrU: Development and validation of a measure to assess personal utility of genomic results. Genet Med 2023; 25 (3): 100356. PubMed PMID:36516964 .
